Minimally invasive retroperitoneal lymph node dissection in testicular cancer reduces length of stay while obtaining a perioperative safety profile comparable to that seen with the open procedure, researchers from the University of California, San Diego Health System reported.
More than 84% of patients with interstitial cystitis (IC) have tried complementary and alternative medicine (CAM) therapies, including dietary changes and physical therapy, and 55% report that their physicians have recommended CAM, according to findings from a recently published survey.
The FDA has approved a broader indication for the advanced prostate cancer treatment abiraterone acetate (ZYTIGA).
The majority of patients undergoing robot-assisted laparoscopic prostatectomy surgery for localized prostate cancer do not regret their treatment decision, according to a recent study.
Percutaneous tibial nerve stimulation (PTNS) and sacral nerve stimulation (SNS) are safe and efficacious for the treatment of overactive bladder, although the former is much more cost effective, results of a recent study indicate.
Nearly all U.S. urology offices (95.4%) still accept Medicare and two-thirds accept Medicaid, according to a recent report that suggests acceptance rates among all medical offices may be declining.Overall, 83.6% of U.S. medical offices accept Medicare and 67% accept Medicaid, the study found.
A study of more than 33,000 outpatient male veterans suggests that a duration of antimicrobial treatment of more than 7 days for a urinary tract infection (UTI) does not reduce the risk of early or late recurrence compared to a shorter duration (7 days or less) of treatment.
An orally bioavailable tyrosine kinase inhibitor demonstrated dramatic and rapid effects on advanced prostate cancer, according to researchers from the University of Michigan Comprehensive Cancer Center, Ann Arbor.
Image-guided targeted biopsy can be used to diagnose prostate cancer, potentially offering a more accurate approach than traditional blind biopsy, according to a recently published study.
Urinary continence and sexual function scores are similar up to 2 years after robot-assisted and open radical prostatectomy, especially when the procedures are performed by skilled, high-volume surgeons, new research shows.
Ajay Singla, MD, has joined The University of Toledo Medical Center, Toledo, OH, and separately, David M. Barrett, MD, has been elected to the board of directors of ProUroCare Medical Inc. in Minneapolis.
Joseph E. Murray, MD, a surgeon and Nobel Prize winner who conducted the world?s first successful organ transplant, died Nov. 26 at age 93.
About half of physicians treating patients with advanced renal cell carcinoma (RCC) believe that working with a comprehensive care team is extremely beneficial in helping to effectively manage adverse events associated with newer targeted therapies, according to a recently released survey.
Isolated cryptorchidism is linked to a higher likelihood of testicular cancer development, say researchers from the United Kingdom.
AVEO Oncology and Astellas Pharma Inc. have announced that the FDA has accepted for filing the new drug application (NDA) for tivozanib with the proposed indication for the treatment of patients with advanced renal cell carcinoma.
In this interview, Laurence Klotz, MD, discusses his group's active surveillance protocol for men with favorable-risk prostate cancer, which men are candidates, how they are monitored, and triggers for active treatment.
Good long-term cancer-specific outcome is possible in well-selected prostate cancer patients found to have lymph node-positive disease at radical prostatectomy, findings from analyses based on 30 years of experience at a single institution demonstrate.
If patients are surprised by a complication and/or adverse outcome, a lawsuit is more likely than if the risks/benefits are explained and create realistic expectations of outcomes for that particular patient and are documented in the medical record.
Generally speaking, for Stage 2 of meaningful use, the bar has been raised; the threshold for measures is higher than it was in Stage 1.
The re-election of President Obama and the strengthened numbers of Democrats in both the House and Senate mean that key provisions of the Affordable Care Act are likely to be implemented over the next 2 years.
A group of researchers at Cornell University's Weill Medical College, New York is using magnetic resonance imaging technology at 7 Tesla to obtain prostate tissue images whose resolution rivals that seen with hematoxylin and eosin (H&E) stains.
Finding ways to retain the superstars who make your urology practice shine-without risking your profitability-is critical to your practice's long-term success.
In experienced hands, holmium laser enucleation of the prostate in men with BPH with glands 200 grams or greater yields outcomes similar to those of simple open prostatectomy with much less morbidity, according to a retrospective review at a single center.
There may be just one predictor of urinary incontinence after pelvic organ prolapse repair-urinary incontinence.
In this article, we cover a few issues gleaned from the 1,362-page final rule that could have an effect on your urology practice.
Heading into 2013, urologists remain deeply concerned about declining reimbursement for their services, increasing government regulations, and implementation of the Affordable Care Act, according to the 2012 Urology Times State of the Specialty survey.
A study investigating trends in ambulatory surgery for stress urinary incontinence shows a significant fourfold increase in the annual rate of sling procedures performed over a contemporary 9-year period, and yet, submucosal injection therapy appears to be maintaining a niche for the treatment of certain patients, report researchers from the University of Michigan, Ann Arbor.
The key to determining what to invest in should be based primarily on the needs, temperament, and available resources of each individual or family.
Men taking statin drugs had a modest reduction in prostate growth in a new analysis of a 4-year, large, randomized trial of the dual 5-alpha-reductase inhibitor dutasteride (Avodart) versus placebo for risk reduction of prostate cancer among high-risk men.
Photoselective vaporization of the prostate using the GreenLight XPS 180W laser system (American Medical Systems, Minnetonka, MN) is associated with reduced operative time and fiber usage compared with the GreenLight HPS 120W while resulting in lower PSA levels 6 months post-procedure.